CIK 0001357459 · Non-accelerated filer<br>Smaller reporting company
PALISADE BIO, INC.
Sign in to watch- Ticker
- PALI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 522007292
- Phone
- (858) 704-4900
- Business address
- 7750 EL CAMINO REAL, SUITE 5200, CARLSBAD, CA, 92009
- Former names
- PALISADE BIO, INC., Seneca Biopharma, Inc., Neuralstem, Inc.
- Open-market buys, last 90 days
- $28,800
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$28,800. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-11 | Finley John David CEO, CFO, Director | Grant or award · Restricted Stock Units | +66,700 | 66,700 | ||
| 2023-06-11 | Finley John David CEO, CFO, Director | Grant or award · Common Stock Options | +148,500 | 148,500 | ||
| 2023-06-11 | Neal James R Director | Grant or award · Restricted Stock Units | +5,100 | 5,100 | ||
| 2023-06-11 | Neal James R Director | Grant or award · Common Stock Options | +12,160 | 12,160 | ||
| 2023-06-11 | Williams Donald Allen Director | Grant or award · Restricted Stock Units | +5,100 | 5,100 | ||
| 2023-06-11 | Williams Donald Allen Director | Grant or award · Common Stock Options | +12,160 | 12,160 | ||
| 2023-06-11 | Csimma Cristina Director | Grant or award · Restricted Stock Units | +6,980 | 6,980 | ||
| 2023-06-11 | Csimma Cristina Director | Grant or award · Common Stock Options | +9,580 | 9,580 | ||
| 2023-06-11 | Wei Binxian Director | Grant or award · Restricted Stock Units | +6,980 | 6,980 | ||
| 2023-06-11 | Wei Binxian Director | Grant or award · Common Stock Options | +9,580 | 9,580 | ||
| 2023-06-11 | Diaz Stephanie Director | Grant or award · Restricted Stock Units | +6,980 | 6,980 | ||
| 2023-06-11 | Diaz Stephanie Director | Grant or award · Common Stock Options | +9,580 | 9,580 | ||
| 2023-04-03 | McRae Robert Curtis Chief Operating Officer | Option exercise | +655 | 895 | ||
| 2023-04-03 | McRae Robert Curtis Chief Operating Officer | Shares withheld for taxes | −270 | $2.00 | $540 | 625 |
| 2023-04-03 | McRae Robert Curtis Chief Operating Officer | Option exercise · Restricted Stock Units | −655 | 1,963 | ||
| 2023-04-03 | Finley John David CEO, CFO, Director | Option exercise | +1,309 | 4,283 | ||
| 2023-04-03 | Finley John David CEO, CFO, Director | Shares withheld for taxes | −435 | $2.01 | $874 | 3,848 |
| 2023-04-03 | Finley John David CEO, CFO, Director | Option exercise · Restricted Stock Units | −1,309 | 3,927 | ||
| 2023-02-06 | Finley John David CEO, CFO, Director | Grant or award · Restricted Stock Units | +41,700 | 41,700 | ||
| 2023-02-06 | Finley John David CEO, CFO, Director | Grant or award · Restricted Performance Stock Units | +32,500 | 32,500 |
Page 11 of 12 · 233 trades